Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Morphic Holding Inc market cap is $2.86B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Morphic Holding Inc 52 week high is $57.00 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Morphic Holding Inc 52 week low is $19.35 as of November 21, 2026.
Morphic Holding Inc stock price today is $56.98.
Morphic Holding Inc stock price yesterday was $56.97.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Morphic Holding Inc's P/E ratio is -15.81.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Morphic Holding Inc P/B ratio is 4.6169.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Morphic Holding Inc 50-day moving average is $48.72.